TELEFLEX INCORPORATED Cost of Revenue
TELEFLEX INCORPORATED (TFX) reported Cost of Revenue of $238.63 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement
us-gaap:CostOfGoodsAndServicesSold · last filed 2026-08-06
- TELEFLEX INCORPORATED cost of goods and services sold for the quarter ending 2026-06-30 was $238.63M, a 35.05% increase year-over-year.
- TELEFLEX INCORPORATED cost of goods and services sold for the quarter ending 2026-03-31 was $240.84M, a 51.63% increase year-over-year.
- TELEFLEX INCORPORATED cost of goods and services sold for the quarter ending 2025-12-31 was -$250.45M.
- TELEFLEX INCORPORATED cost of goods and services sold for the quarter ending 2025-09-28 was $461.38M, a 38.05% increase year-over-year.
- TELEFLEX INCORPORATED cost of goods and services sold for fiscal 2025 was $871.96M, a 31.68% increase from fiscal 2024.
- TELEFLEX INCORPORATED cost of goods and services sold for fiscal 2024 was $662.16M, a 1.51% decline from fiscal 2023.
- TELEFLEX INCORPORATED cost of goods and services sold for fiscal 2023 was $672.33M, a 46.64% decline from fiscal 2022.
- TELEFLEX INCORPORATED cost of goods and services sold for fiscal 2022 was $1.26B, a 0.00% decline from fiscal 2021.
| Period end | Cost of Goods and Services Sold 3 month | Cost of Goods and Services Sold 3 month as first filed | Cost of Goods and Services Sold 6 month | Cost of Goods and Services Sold 6 month as first filed | Cost of Goods and Services Sold 9 month | Cost of Goods and Services Sold 9 month as first filed | Cost of Goods and Services Sold 12 month | Cost of Goods and Services Sold 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $238.63M 10-Q · filed 2026-08-06 | $479.46M 10-Q · filed 2026-08-06 | $229.01M derived: sum of 3 quarters · filed 2026-08-06 | $690.39M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2026-03-31 | $240.84M 10-Q · filed 2026-05-07 | -$9.62M derived: sum of 2 quarters · filed 2026-05-07 | $451.76M derived: sum of 3 quarters · filed 2026-05-07 | $628.46M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-12-31 | -$250.45M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $210.93M derived: sum of 2 quarters · filed 2026-02-27 | $387.62M derived: sum of 3 quarters · filed 2026-08-06 | $871.96M 10-K · filed 2026-02-27 | ||||
| 2025-09-28 | $461.38M 10-Q · filed 2025-11-06 | $638.07M derived: sum of 2 quarters · filed 2026-08-06 | $1.12B 10-Q · filed 2025-11-06 | $469.91M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-06-29 | $176.69M 10-Q · filed 2026-08-06 | $349.80M 10-Q · filed 2025-07-31 | $335.52M 10-Q · filed 2026-08-06 | $661.03M 10-Q · filed 2025-07-31 | $8.53M derived: sum of 3 quarters · filed 2026-08-06 | $342.73M derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2025-03-30 | $158.83M 10-Q · filed 2026-05-07 | $311.23M 10-Q · filed 2025-05-01 | -$168.16M derived: sum of 2 quarters · filed 2026-05-07 | $166.04M derived: sum of 3 quarters · filed 2026-05-07 | $499.27M derived: sum of 4 quarters · filed 2026-05-07 | |||
| 2024-12-31 | -$326.99M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $7.21M derived: sum of 2 quarters · filed 2026-02-27 | $340.44M derived: sum of 3 quarters · filed 2026-02-27 | $662.16M 10-K · filed 2026-02-27 | $1.34B 10-K · filed 2025-02-28 | |||
| 2024-09-29 | $334.20M 10-Q · filed 2025-11-06 | $667.44M derived: sum of 2 quarters · filed 2025-11-06 | $989.15M 10-Q · filed 2025-11-06 | $676.41M derived: sum of 4 quarters · filed 2026-02-27 | ||||
| 2024-06-30 | $333.23M 10-Q · filed 2025-07-31 | $654.95M 10-Q · filed 2025-07-31 | $342.21M derived: sum of 3 quarters · filed 2026-02-27 | $672.29M derived: sum of 4 quarters · filed 2026-02-27 | ||||
| 2024-03-31 | $321.71M 10-Q · filed 2025-05-01 | $8.98M derived: sum of 2 quarters · filed 2026-02-27 | $339.06M derived: sum of 3 quarters · filed 2026-02-27 | $674.49M derived: sum of 4 quarters · filed 2026-02-27 | ||||
| 2023-12-31 | -$312.74M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $17.34M derived: sum of 2 quarters · filed 2026-02-27 | $352.78M derived: sum of 3 quarters · filed 2026-02-27 | $672.33M 10-K · filed 2026-02-27 | $1.33B 10-K · filed 2024-02-23 | |||
| 2023-10-01 | $330.08M 10-Q · filed 2024-10-31 | $665.51M derived: sum of 2 quarters · filed 2024-10-31 | $985.07M 10-Q · filed 2024-10-31 | $1.32B derived: sum of 4 quarters · filed 2025-02-28 | ||||
| 2023-07-02 | $335.44M 10-Q · filed 2024-08-02 | $654.99M 10-Q · filed 2024-08-02 | $990.92M derived: sum of 3 quarters · filed 2025-02-28 | $1.30B derived: sum of 4 quarters · filed 2025-02-28 | ||||
| 2023-04-02 | $319.55M 10-Q · filed 2024-05-03 | $655.48M derived: sum of 2 quarters · filed 2025-02-28 | $968.32M derived: sum of 3 quarters · filed 2025-02-28 | $1.28B derived: sum of 4 quarters · filed 2025-02-28 | ||||
| 2022-12-31 | $335.93M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $648.76M derived: sum of 2 quarters · filed 2025-02-28 | $964.47M derived: sum of 3 quarters · filed 2025-02-28 | $1.26B 10-K · filed 2025-02-28 | ||||
| 2022-09-25 | $312.83M 10-Q · filed 2023-11-03 | $628.54M derived: sum of 2 quarters · filed 2023-11-03 | $924.02M 10-Q · filed 2023-11-03 | $1.27B derived: sum of 4 quarters · filed 2024-02-23 | ||||
| 2022-06-26 | $315.71M 10-Q · filed 2023-08-03 | $611.19M 10-Q · filed 2023-08-03 | $953.37M derived: sum of 3 quarters · filed 2024-02-23 | $1.27B derived: sum of 4 quarters · filed 2024-02-23 | ||||
| 2022-03-27 | $295.48M 10-Q · filed 2023-05-04 | $637.66M derived: sum of 2 quarters · filed 2024-02-23 | $950.13M derived: sum of 3 quarters · filed 2024-02-23 | $1.27B derived: sum of 4 quarters · filed 2024-02-23 | ||||
| 2021-12-31 | $342.18M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-23 | $654.65M derived: sum of 2 quarters · filed 2024-02-23 | $970.56M derived: sum of 3 quarters · filed 2024-02-23 | $1.26B 10-K · filed 2024-02-23 | ||||
| 2021-09-26 | $312.46M 10-Q · filed 2022-10-27 | $628.38M derived: sum of 2 quarters · filed 2022-10-27 | $917.78M 10-Q · filed 2022-10-27 | $1.25B derived: sum of 4 quarters · filed 2023-02-23 | ||||
| 2021-06-27 | $315.92M 10-Q · filed 2022-07-28 | $605.32M 10-Q · filed 2022-07-28 | $932.94M derived: sum of 3 quarters · filed 2023-02-23 | $1.23B derived: sum of 4 quarters · filed 2023-02-23 | ||||
| 2021-03-28 | $289.40M 10-Q · filed 2022-04-28 | $617.02M derived: sum of 2 quarters · filed 2023-02-23 | $916.00M derived: sum of 3 quarters · filed 2023-02-23 | $1.20B derived: sum of 4 quarters · filed 2023-02-23 | ||||
| 2020-12-31 | $327.63M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $626.60M derived: sum of 2 quarters · filed 2023-02-23 | $915.26M derived: sum of 3 quarters · filed 2023-02-23 | $1.21B 10-K · filed 2023-02-23 | ||||
| 2020-09-27 | $298.98M 10-Q · filed 2021-10-28 | $587.64M derived: sum of 2 quarters · filed 2021-10-28 | $884.66M 10-Q · filed 2021-10-28 | $1.19B derived: sum of 4 quarters · filed 2022-03-01 | ||||
| 2020-06-28 | $288.66M 10-Q · filed 2021-07-29 | $585.68M 10-Q · filed 2021-07-29 | $888.91M derived: sum of 3 quarters · filed 2022-03-01 | $1.18B derived: sum of 4 quarters · filed 2022-03-01 | ||||
| 2020-03-29 | $297.02M 10-Q · filed 2021-04-29 | $600.25M derived: sum of 2 quarters · filed 2022-03-01 | $893.49M derived: sum of 3 quarters · filed 2022-03-01 | $1.19B derived: sum of 4 quarters · filed 2022-03-01 | ||||
| 2019-12-31 | $303.23M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $596.47M derived: sum of 2 quarters · filed 2022-03-01 | $896.74M derived: sum of 3 quarters · filed 2022-03-01 | $1.19B 10-K · filed 2022-03-01 | $1.10B 10-K · filed 2020-02-21 | |||
| 2019-09-29 | $293.24M 10-Q · filed 2020-10-29 | $272.64M 10-Q · filed 2019-10-31 | $593.51M derived: sum of 2 quarters · filed 2020-10-29 | $883.13M 10-Q · filed 2020-10-29 | $821.06M 10-Q · filed 2019-10-31 | $1.24B derived: sum of 4 quarters · filed 2021-02-25 | ||
| 2019-06-30 | $300.27M 10-Q · filed 2020-07-30 | $279.58M 10-Q · filed 2019-08-01 | $589.88M 10-Q · filed 2020-07-30 | $548.42M 10-Q · filed 2019-08-01 | $947.30M derived: sum of 3 quarters · filed 2021-02-25 | $1.21B derived: sum of 4 quarters · filed 2021-02-25 | ||
| 2019-03-31 | $289.61M 10-Q · filed 2020-04-30 | $268.84M 10-Q · filed 2019-05-02 | $647.03M derived: sum of 2 quarters · filed 2021-02-25 | $914.13M derived: sum of 3 quarters · filed 2021-02-25 | $1.18B derived: sum of 4 quarters · filed 2021-02-25 | |||
| 2018-12-31 | $357.42M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $624.52M derived: sum of 2 quarters · filed 2021-02-25 | $889.61M derived: sum of 3 quarters · filed 2021-02-25 | $1.15B 10-K · filed 2021-02-25 | $1.06B 10-K · filed 2019-02-21 | |||
| 2018-09-30 | $267.10M 10-Q · filed 2019-10-31 | $532.19M derived: sum of 2 quarters · filed 2019-10-31 | $788.15M 10-Q · filed 2019-10-31 | $1.05B derived: sum of 4 quarters · filed 2020-02-21 | ||||
| 2018-07-01 | $265.09M 10-Q · filed 2019-08-01 | $521.05M 10-Q · filed 2019-08-01 | $785.42M derived: sum of 3 quarters · filed 2020-02-21 | $1.02B derived: sum of 4 quarters · filed 2020-02-21 | ||||
| 2018-04-01 | $255.96M 10-Q · filed 2019-05-02 | $520.34M derived: sum of 2 quarters · filed 2020-02-21 | $759.81M derived: sum of 3 quarters · filed 2020-02-21 | $998.14M derived: sum of 4 quarters · filed 2020-02-21 | ||||
| 2017-12-31 | $264.38M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-21 | $503.85M derived: sum of 2 quarters · filed 2020-02-21 | $742.18M derived: sum of 3 quarters · filed 2020-02-21 | $974.50M 10-K · filed 2020-02-21 | ||||
| 2017-10-01 | $239.48M 10-Q · filed 2018-11-01 | $477.81M derived: sum of 2 quarters · filed 2018-11-01 | $710.13M 10-Q · filed 2018-11-01 | |||||
| 2017-07-02 | $238.33M 10-Q · filed 2018-08-02 | $470.65M 10-Q · filed 2018-08-02 | ||||||
| 2016-12-31 | $871.83M 10-K · filed 2019-02-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |
| PULSE BIOSCIENCES, INC. (PLSE) | United States | $3.696B | -24.47 |
| iRhythm Holdings, Inc. (IRTC) | United States | $3.651B | -281.06 |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |